Radiolabelled PSMA PET/CT in breast cancer. A systematic review.

IF 0.6 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

NUCLEAR MEDICINE REVIEW Pub Date : 2020-01-01 DOI:10.5603/NMR.2020.0004

Francesco Bertagna, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Davide Tomasini, Marco Bonù, Raffaele Giubbini, Giorgio Treglia

{"title":"Radiolabelled PSMA PET/CT in breast cancer. A systematic review.","authors":"Francesco Bertagna, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Davide Tomasini, Marco Bonù, Raffaele Giubbini, Giorgio Treglia","doi":"10.5603/NMR.2020.0004","DOIUrl":null,"url":null,"abstract":"Background: Radiolabelled prostate-specific membrane antigen (PSMA)-based PET/CT is a whole-body imaging technique currently performed for the detection of prostate cancer lesions. PSMA has been also demonstrated to be expressed by the neovasculature of many other solid tumours. The aim of this review is to evaluate the possible diagnostic role of radiolabelled PSMA PET/CT in breast cancer.Material and methods: A comprehensive literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane Library databases was conducted to find relevant published articles about the diagnostic performance of radiolabelled PSMA PET/CT in breast cancer.Results: The comprehensive computer literature search revealed 652 articles. On reviewing the titles and abstracts, 640 articles were excluded because the reported data were not within the field of interest of this review. Twelve articles were selected and retrieved in full-text version; no additional study was found when screening the references of these articles. In total, 12 articles were included in the systematic review.Conclusions: Further studies enrolling a wider population are needed to clarify the.","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"23 1","pages":"32-35"},"PeriodicalIF":0.6000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NUCLEAR MEDICINE REVIEW","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/NMR.2020.0004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 13

Abstract

Background: Radiolabelled prostate-specific membrane antigen (PSMA)-based PET/CT is a whole-body imaging technique currently performed for the detection of prostate cancer lesions. PSMA has been also demonstrated to be expressed by the neovasculature of many other solid tumours. The aim of this review is to evaluate the possible diagnostic role of radiolabelled PSMA PET/CT in breast cancer.

Material and methods: A comprehensive literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane Library databases was conducted to find relevant published articles about the diagnostic performance of radiolabelled PSMA PET/CT in breast cancer.

Results: The comprehensive computer literature search revealed 652 articles. On reviewing the titles and abstracts, 640 articles were excluded because the reported data were not within the field of interest of this review. Twelve articles were selected and retrieved in full-text version; no additional study was found when screening the references of these articles. In total, 12 articles were included in the systematic review.

Conclusions: Further studies enrolling a wider population are needed to clarify the.

查看原文本刊更多论文

放射标记PSMA PET/CT在乳腺癌中的应用。系统回顾。

背景:基于放射标记前列腺特异性膜抗原(PSMA)的PET/CT是目前用于前列腺癌病变检测的一种全身成像技术。PSMA也被证明在许多其他实体肿瘤的新生血管中表达。本综述的目的是评估放射标记PSMA PET/CT在乳腺癌诊断中的可能作用。材料与方法:综合检索PubMed/MEDLINE、Scopus、Embase、Cochrane等数据库，查找放射性标记PSMA PET/CT在乳腺癌诊断中的相关文献。结果:计算机综合文献检索共检索到652篇。在审查标题和摘要时，640篇文章被排除，因为报道的数据不在本综述感兴趣的领域内。选取12篇文章全文检索;在筛选这些文献的参考文献时，未发现其他研究。系统评价共纳入12篇文章。结论:需要进一步的研究，纳入更广泛的人群来澄清。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NUCLEAR MEDICINE REVIEW RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

24 weeks

期刊介绍： Written in English, NMR is a biannual international periodical of scientific and educational profile. It is a journal of Bulgarian, Czech, Hungarian, Macedonian, Polish, Romanian, Russian, Slovak, Ukrainian and Yugoslav Societies of Nuclear Medicine. The periodical focuses on all nuclear medicine topics (diagnostics as well as therapy), and presents original experimental scientific papers, reviews, case studies, letters also news about symposia and congresses. NMR is indexed at Index Copernicus (7.41), Scopus, EMBASE, Index Medicus/Medline, Ministry of Education 2007 (4 pts.).